June's top stories: data integrity issues, conflicts of interest, and how not to handle a CEO succession

Get 25% off an annual STAT+ subscription and access June's top stories to read more. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

www.statnews.com Join the STAT+ community today to get access to last month's top stories and much more. Subscribe now for 25% off your first year. ALEX HOGAN/STAT The inside story of how data integrity issues roiled a biotech seen as 'Moderna 2.0' by Allison DeAngelis READ MORE EROS DERVISHI FOR STAT 'It's beyond unethical': Opaque conflicts of interest permeate prescription drug benefits by Bob Herman READ MORE JEFF SPICER/PA WIRE VIA AP Francis deSouza's tenure at Illumina is a lesson in how not to handle CEO succession by Matthew Herper READ MORE MORE TOP STORIES Hospitals want to buy doctors' happiness with Nuance's AI scribe. What they're paying varies by Brittany Trang Biotech executive nominated to Biogen board is mother of director's child, records show by Damian Garde and Adam Feuerstein How Blue Cross Blue Shield insurers ratcheted up profits in 2022 by Bob Herman Bitter infighting leads 15 chapters to break away from leading ALS advocacy group by Ed Silverman Evangelist for legalizing MDMA therapy wrestles with his ideals as psychedelics go pharma by Olivia Goldhill FDA's letter to medical device maker iRhythm is a warning for the industry by Lizzy Lawrence Ozempic 3.0? Lilly's 'triple-G' drug shows biggest weight loss yet in mid-stage trial by Elaine Chen   SUBSCRIBE Thursday, July 6, 2023       1 Exchange Place, Boston, MA 02109 ©2023, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us